QUESTRAN (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the QUESTRAN drug offered from Par Pharmaceutical, Inc.. This Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Cholestyramine |
SUBSTANCE NAME: | CHOLESTYRAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | POWDER, FOR SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-09-15 |
END MARKETING DATE: | 0000-00-00 |
QUESTRAN HUMAN PRESCRIPTION DRUG Details:
Item Description | QUESTRAN from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(g/9g) |
START MARKETING DATE: | 2005-09-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49884-936_cbafb444-c4f5-4230-8d90-b023aaca26ea |
PRODUCT NDC: | 49884-936 |
APPLICATION NUMBER: | ANDA077204 |
Other CHOLESTYRAMINE Pharmaceutical Manufacturers / Labelers: